Vermulst M: Difference between revisions
From Bioblast
m (moved Vermulst Mark to Vermulst M over redirect) |
Beno Marija (talk | contribs) |
||
Line 17: | Line 17: | ||
|field of research=Basic | |field of research=Basic | ||
}} | }} | ||
== | == Participated at== | ||
* [[MiPNet19.06 IOC91 |IOC91 Philadelphia]] | ::::* [[MiPNet19.06 IOC91 |IOC91 Philadelphia]] |
Revision as of 15:04, 14 June 2017
Name | Vermulst Mark, |
---|---|
Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia - Research Institute Colket Translational Research Building |
Address | 3501 Civic Center Blvd, 19104 |
City | Philadelphia |
State/Province | Pennsylvania (PA) |
Country | USA |
[email protected] | |
Weblink | |
O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
McManus 2019 Cell Metab | 2019 | McManus MJ, Picard M, Chen HW, De Haas HJ, Potluri P, Leipzig J, Towheed A, Angelin A, Sengupta P, Morrow RM, Kauffman BA, Vermulst M, Narula J, Wallace DC (2019) Mitochondrial DNA variation dictates expressivity and progression of nuclear DNA mutations causing cardiomyopathy. Cell Metab 29:78-90. |